Biodesix Inc. (BDSX) Financial Statements (2024 and earlier)

Company Profile

Business Address 2970 WILDERNESS PLACE
BOULDER, CO 80301
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments43,08832,71262,126
Cash and cash equivalents43,08832,71262,126
Receivables5,0653,65615,304
Inventory, net of allowances, customer advances and progress billings(100)  
Inventory(100)  
Other current assets5,1817,2458,710
Other undisclosed current assets100  
Total current assets:53,33443,61386,140
Noncurrent Assets
Operating lease, right-of-use asset2,973  
Property, plant and equipment5,8484,1793,178
Intangible assets, net (including goodwill)24,82826,64828,291
Goodwill15,03115,03115,031
Intangible assets, net (excluding goodwill)9,79711,61713,260
Other noncurrent assets5,9231,6573,461
Total noncurrent assets:39,57232,48434,930
TOTAL ASSETS:92,90676,097121,070
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,9039,32716,753
Accounts payable1,6851,6628,964
Accrued liabilities8,2187,6657,789
Deferred revenue9621,8503,532
Debt491911,840
Business combination, contingent consideration, liability10,34117,764 
Other liabilities41  
Other undisclosed current liabilities1,543  
Total current liabilities:22,83928,96032,125
Noncurrent Liabilities
Long-term debt and lease obligation25,0049,99315,926
Long-term debt, excluding current maturities25,0049,99315,926
Liabilities, other than long-term debt24,45717,41731,853
Other liabilities5581,3891,921
Operating lease, liability5,254  
Business combination, contingent consideration, liability 18,64516,02829,932
Total noncurrent liabilities:49,46127,41047,779
Total liabilities:72,30056,37079,904
Equity
Equity, attributable to parent20,60619,72741,166
Common stock783127
Additional paid in capital387,948321,669299,953
Accumulated deficit(367,420)(301,973)(258,814)
Total equity:20,60619,72741,166
TOTAL LIABILITIES AND EQUITY:92,90676,097121,070

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues38,21254,50645,557
Cost of revenue
(Cost of Goods and Services Sold)
(906)  
Gross profit:37,30654,50645,557
Operating expenses(88,799)(95,446)(68,491)
Other undisclosed operating income906  
Operating loss:(50,587)(40,940)(22,934)
Nonoperating expense
(Other Nonoperating expense)
(14,860)(2,219)(8,416)
Interest and debt expense(6,981)(2,210)(7,604)
Loss from continuing operations:(72,428)(45,369)(38,954)
Loss before gain (loss) on sale of properties:(45,369)(38,954)
Other undisclosed net income6,9812,2107,604
Net loss available to common stockholders, diluted:(65,447)(43,159)(31,350)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(65,447)(43,159)(31,350)
Comprehensive loss, net of tax, attributable to parent:(65,447)(43,159)(31,350)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: